📣 VC round data is live. Check it out!
- Public Comps
- Deepnoid
Deepnoid Valuation Multiples
Discover revenue and EBITDA valuation multiples for Deepnoid and similar public comparables like SMAIO, DarioHealth, PharmX Technologies, BIT Computer and more.
Deepnoid Overview
About Deepnoid
Deepnoid Inc is a doctor-driven medical AI platform. It is an open platform that supports doctor-led medical imaging AI model research efficiently. It uses both the image processing module and neural network module provided by default for free, and can effectively use computing resources in the form of a cloud.
Founded
2008
HQ

Employees
89
Website
Sectors
Financials (FY)
EV
$45M
Valuation Multiples
Start free trialDeepnoid Financials
Deepnoid reported last fiscal year revenue of $5M and negative EBITDA of ($6M).
In the same fiscal year, Deepnoid generated $3M in gross profit, ($6M) in EBITDA losses, and had net loss of ($7M).
Deepnoid P&L
In the most recent fiscal year, Deepnoid reported revenue of $5M and EBITDA of ($6M).
Deepnoid is unprofitable as of last fiscal year, with gross margin of 64%, EBITDA margin of (127%), and net margin of (144%).
Financial data powered by Morningstar, Inc.
Deepnoid Stock Performance
Deepnoid has current market cap of $57M, and enterprise value of $45M.
Market Cap Evolution
Deepnoid's stock price is $2.32.
Deepnoid share price decreased by 4.3% in the last 30 days, and by 38.6% in the last year.
Deepnoid has an EPS (earnings per share) of $-0.30.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $45M | $57M | -5.8% | -4.3% | -6.6% | -38.6% | $-0.30 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialDeepnoid Valuation Multiples
Deepnoid trades at 8.9x EV/Revenue multiple, and (7.0x) EV/EBITDA.
Deepnoid Financial Valuation Multiples
As of May 8, 2026, Deepnoid has market cap of $57M and EV of $45M.
Deepnoid has a P/E ratio of (7.7x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Deepnoid Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Deepnoid Margins & Growth Rates
In the most recent fiscal year, Deepnoid reported gross margin of 64%, EBITDA margin of (127%), and net margin of (144%).
Deepnoid Margins
Deepnoid Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Deepnoid Operational KPIs
Deepnoid's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
Deepnoid Competitors
Deepnoid competitors include SMAIO, DarioHealth, PharmX Technologies, BIT Computer, SOFTMAX, tripla, MeVis, Chandan Healthcare, Oncocross and NetraMark.
Most Deepnoid public comparables operate across Artificial Intelligence, Health Data & Analytics, Healthcare Software, Medical Imaging & Diagnostics, Vertical AI Applications, B2B SaaS, DeepTech, HealthTech and Vertical SaaS.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 5.2x | 4.6x | (53.9x) | (56.8x) | |||
| 2.9x | 2.7x | (2.7x) | (3.0x) | |||
| 10.0x | — | 52.8x | — | |||
| 1.4x | — | 4.9x | — | |||
| 1.1x | 1.1x | 9.2x | — | |||
| (3.3x) | (2.8x) | (12.9x) | — | |||
| 2.2x | — | 10.5x | — | |||
| 2.9x | — | 15.4x | — | |||
This data is available for Pro users. Sign up to see all Deepnoid competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Deepnoid
| When was Deepnoid founded? | Deepnoid was founded in 2008. |
| Where is Deepnoid headquartered? | Deepnoid is headquartered in South Korea. |
| How many employees does Deepnoid have? | As of today, Deepnoid has over 89 employees. |
| Is Deepnoid publicly listed? | Yes, Deepnoid is a public company listed on Korea Exchange. |
| What is the stock symbol of Deepnoid? | Deepnoid trades under 315640 ticker. |
| When did Deepnoid go public? | Deepnoid went public in 2021. |
| Who are competitors of Deepnoid? | Deepnoid main competitors include SMAIO, DarioHealth, PharmX Technologies, BIT Computer, SOFTMAX, tripla, MeVis, Chandan Healthcare, Oncocross, NetraMark. |
| What is the current market cap of Deepnoid? | Deepnoid's current market cap is $57M. |
| What is the current revenue of Deepnoid? | Deepnoid's last fiscal year revenue is $5M. |
| What is the current EV/Revenue multiple of Deepnoid? | Current revenue multiple of Deepnoid is 8.9x. |
| Is Deepnoid profitable? | No, Deepnoid is not profitable. |
| How many companies Deepnoid has acquired to date? | Deepnoid hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Deepnoid has invested to date? | Deepnoid hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Deepnoid
Lists including Deepnoid
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.